Sunshine Act Meeting
| Published date | 22 July 2021 |
| Citation | 86 FR 38713 |
| Record Number | 2021-15734 |
| Section | Notices |
| Court | Federal Election Commission |
38713
Federal Register / Vol. 86, No. 138 / Thursday, July 22, 2021 / Notices
ENVIRONMENTAL PROTECTION
AGENCY
[FRL–8712–01–R6]
Public Water System Supervision
Program Revision for the State of
Texas
AGENCY
: Environmental Protection
Agency (EPA).
ACTION
: Notice of tentative approval.
SUMMARY
: Notice is hereby given that
the State of Texas is revising its
approved Public Water System
Supervision (PWSS) program. Texas has
adopted the Environmental Protection
Agency (EPA) drinking water rule for
Variance and Exemptions (V&E). EPA
has determined that the proposed V&E
Rule submitted by Texas is no less
stringent than the corresponding federal
regulations. Therefore, EPA intends to
approve this PWSS program revision
package.
DATES
: All interested parties may
request a public hearing. A request for
a public hearing must be submitted by
August 23, 2021 to the Regional
Administrator at the EPA Region 6
address shown below. Frivolous or
insubstantial requests for a hearing may
be denied by the Regional
Administrator. However, if a substantial
request for a public hearing is made by
August 23, 2021, a public hearing will
be held. If no timely and appropriate
request for a hearing is received and the
Regional Administrator does not elect to
hold a hearing on his own motion, this
determination shall become final and
effective on August 23, 2021. Any
request for a public hearing shall
include the following information: The
name, address, and telephone number of
the individual, organization, or other
entity requesting a hearing; a brief
statement of the requesting person’s
interest in the Regional Administrator’s
determination and a brief statement of
the information that the requesting
person intends to submit at such
hearing; and the signature of the
individual making the request, or, if the
request is made on behalf of an
organization or other entity, the
signature of a responsible official of the
organization or other entity.
ADDRESSES
: All documents relating to
this determination are available for
inspection between the hours of 8:00
a.m. and 4:30 p.m., Monday through
Friday, at the following offices: Texas
Commission on Environmental Quality,
Water Supply Division, Public Drinking
Water Section (MC–155), Building F,
12100 Park 35 Circle, Austin, TX 78753;
and United States Environmental
Protection Agency, Region 6, Drinking
Water Section (6WD–DD), 1201 Elm St,
Dallas, TX 75270.
FOR FURTHER INFORMATION CONTACT
: Jose
´
G. Rodriguez, EPA Region 6, Drinking
Water Section at the Dallas address
given above, or by telephone at (214)
665–8087, or by email at
rodriguez.jose@epa.gov.
Authority: Section 1413 of the Safe
Drinking Water Act, as amended (1996),
and 40 CFR part 142 of the National
Primary Drinking Water Regulations.
Dated: July 9, 2021.
David Gray,
Acting Regional Administrator, Region 6.
[FR Doc. 2021–15470 Filed 7–21–21; 8:45 am]
BILLING CODE 6560–50–P
FEDERAL DEPOSIT INSURANCE
CORPORATION
Sunshine Act Meetings; Notice of a
Matter To Be Deferred From the
Agenda for Consideration at an
Agency Meeting
FEDERAL REGISTER CITATION OF PREVIOUS
ANNOUNCEMENT
: The previously
announced meeting agenda of the Board
of Directors, published at 86 FR 37752,
has changed.
PREVIOUSLY ANNOUNCED TIME AND DATE OF
THE MEETING
: Tuesday, July 20, 2021, at
10:00 a.m.
CHANGES IN THE MEETING
: Pursuant to the
provisions of the ‘‘Government in the
Sunshine Act’’ (5 U.S.C. 552b), notice is
hereby given that the following matter
will be deferred from the Summary
Agenda at the open meeting of the
Board of Directors of the Federal
Deposit Insurance Corporation
scheduled to be held at 10:00 a.m. on
July 20, 2021, via a Webcast live on the
internet:
Memorandum and resolution re:
Notice of Proposed Rulemaking on
Revisions to Standardized Approach for
Calculating the Exposure Amount of
Derivative Contracts.
CONTACT PERSON FOR MORE INFORMATION
:
Requests for further information
concerning the meeting may be directed
to Debra A. Decker, Deputy Executive
Secretary of the Corporation, at (202)
898–8748.
Federal Deposit Insurance Corporation.
Dated at Washington, DC, on July 19, 2021.
James P. Sheesley,
Assistant Executive Secretary.
[FR Doc. 2021–15672 Filed 7–20–21; 11:15 am]
BILLING CODE 6714–01–P
FEDERAL DEPOSIT INSURANCE
CORPORATION
Sunshine Act Meeting
TIME AND DATE
: 10:17 a.m. on Tuesday,
July 20, 2021.
PLACE
: The meeting was held via video
conference on the internet.
STATUS
: Closed.
MATTERS TO BE CONSIDERED
: In calling
the meeting, the Board determined, on
motion of Director Martin J. Gruenberg,
seconded by Director Michael J. Hsu
(Acting Comptroller of the Currency),
and concurred in by Director David
Uejio (Acting Director, Consumer
Financial Protection Bureau), and
Chairman Jelena McWilliams, that
Corporation business required its
consideration of the matters which were
to be the subject of this meeting on less
than seven days’ notice to the public;
that no earlier notice of the meeting was
practicable; that the public interest did
not require consideration of the matters
in a meeting open to public observation;
and that the matters could be
considered in a closed meeting by
authority of subsections (c)(4), (c)(6),
(c)(8), (c)(9)(A)(ii), and (c)(9)(B) of the
‘‘Government in the Sunshine Act’’ (5
U.S.C. 552b(c)(4), (c)(6), (c)(8),
(c)(9)(A)(ii), and (c)(9)(B).
CONTACT PERSON FOR MORE INFORMATION
:
Requests for further information
concerning the meeting may be directed
to Debra A. Decker, Deputy Executive
Secretary of the Corporation, at 202–
898–8748.
Dated this the 20th day of July, 2021.
Federal Deposit Insurance Corporation.
James P. Sheesley,
Assistant Executive Secretary.
[FR Doc. 2021–15729 Filed 7–20–21; 4:15 pm]
BILLING CODE 6714–01–P
FEDERAL ELECTION COMMISSION
Sunshine Act Meeting
TIME AND DATE
: Tuesday, July 27, 2021
at 10:00 a.m. and its continuation at the
conclusion of the open meeting on July
29, 2021.
PLACE
: 1050 First Street NE,
Washington, DC (This meeting will be a
virtual meeting).
STATUS
: This meeting will be closed to
the public.
MATTERS TO BE CONSIDERED
: Compliance
matters pursuant to 52 U.S.C. § 30109.
Matters concerning participation in
civil actions or proceedings or
arbitration.
* * * * *
VerDate Sep<11>2014 17:10 Jul 21, 2021 Jkt 253001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\22JYN1.SGM 22JYN1
lotter on DSK11XQN23PROD with NOTICES1
38714
Federal Register / Vol. 86, No. 138 / Thursday, July 22, 2021 / Notices
CONTACT PERSON FOR MORE INFORMATION
:
Judith Ingram, Press Officer. Telephone:
(202) 694–1220.
Vicktoria J. Allen,
Acting Deputy Secretary of the Commission.
[FR Doc. 2021–15734 Filed 7–20–21; 4:15 pm]
BILLING CODE 6715–01–P
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
applications are set forth in paragraph 7
of the Act (12 U.S.C. 1817(j)(7)).
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than August 6, 2021.
A. Federal Reserve Bank of Dallas
(Karen Smith, Director, Applications)
2200 North Pearl Street, Dallas, Texas
75201–2272:
1. The Vanguard Group, Inc.,
Malvern, Pennsylvania; on behalf of
itself, its subsidiaries and affiliates,
including investment companies
registered under the Investment
Company Act of 1940, other pooled
investment vehicles, and institutional
accounts that are sponsored, managed,
or advised by Vanguard; to acquire
additional voting shares of Comerica
Incorporated, Dallas, Texas, and thereby
indirectly acquire additional voting
shares of Comerica Bank, Dallas, Texas,
and Comerica Bank & Trust, National
Association, Ann Arbor, Michigan.
Board of Governors of the Federal Reserve
System, July 19, 2021.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2021–15593 Filed 7–21–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
AGENCY
: Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION
: Notice.
SUMMARY
: This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project: ‘‘The
AHRQ Safety Program for Methicillin-
Resistant Staphylococcus aureus
(MRSA) Prevention.’’ This proposed
information collection was previously
published in the Federal Register on
May 3rd, 2021 and allowed 60 days for
public comment. AHRQ did not receive
any substantive comments from
members of the public. The purpose of
this notice is to allow an additional 30
days for public comment.
DATES
: Comments on this notice must be
received by August 23, 2021.
ADDRESSES
: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain . Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT
:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION
:
Proposed Project
The AHRQ Safety Program for
Methicillin-Resistant Staphylococcus
aureus (MRSA) Prevention
As part of the HHS HAI National
Action Plan (NAP), AHRQ has
supported the implementation and
adoption of the Comprehensive Unit-
based Safety Program (CUSP) to reduce
Central-Line Associated Bloodstream
Infections (CLABSI) and Catheter-
Associated Urinary Tract Infections
(CAUTI), and subsequently applied
CUSP to other clinical challenges,
including reducing surgical site
infections and improving care for
mechanically ventilated patients. As
part of the National Action Plan for
Combating Antibiotic-Resistant Bacteria
(CARB NAP), the HHS HAI National
Action Plan, and Healthy People 2030
goals, AHRQ will now apply the
principles and concepts that have been
learned from these HAI reduction efforts
to the prevention of MRSA invasive
infections.
Healthcare-associated infections, or
HAIs, are a highly significant cause of
illness and death for patients in the U.S.
At any given time, HAIs affect one out
of every 31 hospital inpatients. More
than a million of these infections occur
across our health care system every
year. This leads to significant patient
harm and loss of life, and costs billions
of dollars each year in medical and non-
medical costs. In addition, the 3 million
Americans currently residing in U.S.
nursing homes experience a staggering
2–3 million HAIs each year.
Particular concern has arisen related
to the persistent prevalence of
methicillin-resistant Staphylococcus
aureus (MRSA). This bacterium affects
both communities and healthcare
facilities, but the majority of morbidity
and mortality occurs in critically and
chronically ill patients. While MRSA
was rare in the US through the 1970s,
its prevalence in US health care
facilities began rising in the 1980s and
has continued to do so. In 2000, MRSA
was responsible for 133,510
hospitalizations in children and adults.
This number more than doubled by
2005, with 278,203 hospitalizations
along with 56,248 septic events and
6,639 deaths being attributed to MRSA.
MRSA has become a major form of
hospital-associated Staphylococcus
aureus infection.
For various patient safety initiatives,
AHRQ has promoted the
implementation and adoption of the
Comprehensive Unit-based Safety
Program (CUSP) approach which
combines clinical and cultural (i.e.,
technical and adaptive) intervention
components to facilitate the
implementation of technical bundles to
improve patient safety. For MRSA
prevention, it is likely that a
combination of technical approaches is
indicated, including decolonization
along with classic infection control
practices such as hand hygiene,
environmental cleaning, general HAI
prevention, and contact precautions/
isolation. Implementation of these
technical approaches would benefit
VerDate Sep<11>2014 17:10 Jul 21, 2021 Jkt 253001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\22JYN1.SGM 22JYN1
lotter on DSK11XQN23PROD with NOTICES1
